Cardiovascular Health

Pharmacists can improve a patient's medication adherence by dispensing information beyond a drug's label.

Patrick Curtin, PharmD, BCPS, Clinical Coordinator at Overlook Medical Center in Summit, New Jersey, addresses how to gauge 10-year atherosclerotic cardiovascular disease risk for patients relative to lifestyle, cholesterol, and obesity.

Patrick Curtin, PharmD, BCPS, Clinical Coordinator at Overlook Medical Center in Summit, New Jersey, identifies some notable changes to previous guidelines as presented in the 2013 ACC/AHA Guidelines on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults.

Energy drink overconsumption has dangerous cardiac and neurologic consequences in adolescents.

Showing gratitude may provide physical benefits to heart failure (HF) patients.

Applying pediatric lipid guidelines to adolescents might result in more than 400,000 additional young adults taking statins.

Despite a 39% decrease in age-specific mortality rates, deaths related to cardiovascular disease increased by 41% globally between 1990 and 2013.

Actavis is seeking FDA approval for its generic version of Gilead Sciences' Letairis pulmonary arterial hypertension treatment.

Readmission rates among patients with heart failure, acute myocardial infarction, and pneumonia increase when psychiatric illness is also present.

Changes to the prescribing information for alteplase (Activase) recently flew in under the radar.

Teva, Mylan, and Sandoz announced the US launches of their generic equivalents to Novartis's Exforge.

Medtronic's CoreValve System is now approved for first-of-its-kind "valve-in-valve" replacement.

A veritable alphabet soup of hypertension guidelines have been released over the past year. Here is what you need to know.

Veterans with post-traumatic stress disorder face greater odds of developing heart failure.

Patients with limited life expectancy may see improvement in their quality of life if they stop taking statins.

As the US Centers for Medicare and Medicaid Services places a greater emphasis on medication adherence through its star ratings, pharmacists and other health care professionals continue to seek ways to improve adherence among seniors.

The 2015 American College of Cardiology Annual Scientific Session and Expo featured the latest discoveries in cardiovascular research.

The FDA today approved a CPR device that the agency claims may improve a patient's chances of surviving cardiac arrest.

Improvements in nutrition, exercise, stress, and sleep may help patients with prediabetes reduce their risk of progressing to type 2 diabetes.

Screening men with erectile dysfunction (ED) for cardiac risk factors could save the health care system $28 billion over a 20-year period.

In light of misrepresented statistics and overstated fears about statin-related adverse events, here are 3 of the biggest myths your patients may have heard about these life-saving medications-and the facts

Labels of prescription testosterone products must now include information about possible cardiovascular and stroke risks associated with their use.

Almost all women and seniors with atrial fibrillation should be receiving blood thinners, advises a new analysis of updated clinical practice guidelines.

Casting doubt on previous conjectures, a new study suggests that statins do not protect patients against Parkinson's disease.

Even short-term treatment with nonsteroidal anti-inflammatory drugs is associated with significant increases in bleeding and cardiovascular event risk in patients receiving antithrombotic therapy after a heart attack.

Is it possible for Twitter to predict a community's level of heart disease?

Simple physical activity such as moving around the house can have a substantial effect on seniors' cardiovascular health.

The risk of heart attack is 8.5 times higher in the 2 hours following bursts of intense anger, suggests research from the University of Sydney.

While statins can effectively reduce cholesterol levels, a new study has found that the medications leave much to be desired in terms of substantially improving cardiovascular symptoms.

Teva Pharmaceutical Industries recently launched generic versions of Sanofi's enoxaparin sodium injection (Lovenox) and Pfizer's linezolid injection (Zyvox).